Skip to main content
. Author manuscript; available in PMC: 2005 Sep 13.
Published in final edited form as: Immunol Invest. 2004 May;33(2):213–233. doi: 10.1081/imm-120034231

Figure 3B. De novo protein synthesis is required for p38 MAPK-mediated IL-6 mRNA synthesis in MC3T3-E1 Cells.

Figure 3B

MC3T3-E1 cells with treated with IL-1 (1.0ng/ml) and SB203580 (2μM) and in the presence or absence of cycloheximide (CHX; 2μg/ml). Semi-quantitative RT-PCR was performed to evaluate IL-6 mRNA expression. See text for details on CHX effects. Means from two indepednent experiments are presented.